HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 55, Issue 1, Pages 211-222 (February 2008)


View previous. 14 of 17 View next.

Rethinking Pediatric Assent: From Requirement to Ideal

Yoram Unguru, MD, MS, MAabCorresponding Author Informationemail address, Max J. Coppes, MD, PhD, MBAacde, Naynesh Kamani, MDfgh

Physician-investigators are required to obtain informed consent from adult participants in their studies. Inclusion of children in research legally requires informed permission of a child’s parent or guardian. It is increasingly recognized that a child need not assume a passive role when included in research, but that his or her active involvement should be sought, as expressed by the child’s assent to partake in clinical research. This article briefly explores the history of assent and the central role of assessing a child’s understanding of research and preference for participating in decisions related to their care, as necessary components of meaningful assent.

a Division of Hematology/Oncology, Center for Cancer and Blood Disorders, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970, USA

b Berman Bioethics Institute, Johns Hopkins University, Hampton House 348, 624 N. Broadway, Baltimore, MD 21205, USA

c Department of Medicine, Georgetown University, 3800 Reservoir Road NW, Washington, DC 20007, USA

d Department of Oncology, Georgetown University, Research Building, Suite E501, 3970 Reservoir Road NW, Washington, DC 20007, USA

e Department of Pediatrics, Georgetown University, 3800 Reservoir Road NW, 2PHC, Washington, DC 20007, USA

f Department of Pediatrics, George Washington University, 2300 Eye Street NW, Suite 713W, Washington, DC 20037, USA

g Department of Immunology, George Washington University, 2300 Eye Street NW, Suite 713W, Washington, DC 20037, USA

h Institutional Review Board, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970, USA

Corresponding Author InformationCorresponding author. Center for Cancer and Blood Disorders, Division of Hematology/Oncology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970.

PII: S0031-3955(07)00159-9

doi:10.1016/j.pcl.2007.10.016


View previous. 14 of 17 View next.